FDA preps for a new and flexible approach to genome editing in animals
With the use of CRISPR proliferating and gene drives on the horizon in the US, the FDA said that it’s now looking at a risk …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
